| Log in

Aurobindo Pharma raising up to $350M through QIP

11 December, 2014

Hyderabad-based drugmaker Aurobindo Pharma Ltd has received its board approval to raise up to $350 million through qualified institutional placement (QIP), as per a stock market disclosure.

The company, however, did not disclose the purpose of raising funds and the time frame for the same.

Founded in 1986, Aurobindo Pharma manufactures active pharmaceutical ingredients, intermediates and generic formulations. The firm got listed in 1992.

It has been increasing its API portfolio and active in acquiring firms in the country.

Earlier this week, Aurobindo Pharma completed the acquisition of American nutritional supplement maker, Natrol Inc, and other affiliate entities through its wholly owned subsidiary Aurobindo Pharma USA Inc.

The Aurobindo Pharma arm had emerged as the highest and best bidder to acquire assets of Natrol under the auction process by the United States Bankruptcy Court for the District of Delaware. It bid $132.5 million (Rs 815 crore) to buy Natrol, which is under bankruptcy protection.

In June this year, the drugmaker also got approval from US Food and Drug Administration (USFDA) to market the generic version of AbbVie Inc’s Depakote ER extended-release tablets, used for treating mental illness, in the American market.

For the September quarter, Aurobindo Pharma’s consolidated net profit grew 58.4 per cent to Rs 372.18 crore, while its net sales increased 50.8 per cent to Rs 2862.19 crore from the same period a year ago.

(Edited by Joby Puthuparampil Johnson)


Leave Your Comment
Plethico to pay $23.3M to Aurobindo for settling dispute over Natrol

Plethico to pay $23.3M to Aurobindo for settling dispute over Natrol

Bhawna Gupta 3 years ago
Indore-based pharmaceutical company Plethico Pharmaceuticals Ltd has agreed to...
Aurobindo emerges top bidder to buy nutritional supplements maker Natrol for $132.5M

Aurobindo emerges top bidder to buy nutritional supplements maker Natrol for $132.5M

Jasleen Kaur Batra 3 years ago
Hyderabad-based Aurobindo Pharma Ltd has emerged as the highest bidder for...
Aurobindo Pharma may acquire a few API units of Actavis in Europe

Aurobindo Pharma may acquire a few API units of Actavis in Europe

TEAM VCC 4 years ago
Hyderabad-based Aurobindo Pharma Ltd is in talks with Dublin-headquartered...
No Comments

Aurobindo Pharma raising up to $350M through QIP

Powered by WordPress.com VIP